Suppression of symptoms of alcohol dependence and craving using high-dose baclofen
- PMID: 17172256
- DOI: 10.1093/alcalc/agl091
Suppression of symptoms of alcohol dependence and craving using high-dose baclofen
Abstract
Aims: To further test whether the baclofen-induced suppression of motivation to consume alcohol in animals could be transposed to humans.
Methods: A patient who had neither tolerated nor benefited from other alcohol treatment modalities was put on trial with baclofen on a dosage up to 140 mg/day.
Results: The patient reported dramatic reduction in cravings for and preoccupation with alcohol.
Conclusions: High-dose baclofen therapy was associated with complete and prolonged suppression of symptoms and consequences of alcohol-dependence.
Comment in
-
Gamma-hydroxybutyrate (GHB)-deficiency in alcohol-dependence?Alcohol Alcohol. 2007 Sep-Oct;42(5):506. doi: 10.1093/alcalc/agm058. Epub 2007 Aug 1. Alcohol Alcohol. 2007. PMID: 17673481 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
